Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Welsh

Showing results (11-20 of 328) with videos related to

Pageof 33
Sort By:
Open Heart|January 14, 2021
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease eventsRosemary Elisabeth Brown, Paul Welsh, Jennifer Logue
Heart (British Cardiac Society)|January 17, 2025
Updating the Scottish national cardiovascular risk score: ASSIGN version 2.0Paul Welsh, Dorien M Kimenai, Mark Woodward
Current Opinion in Lipidology|October 30, 2008
Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the barPaul Welsh, Chris J Packard, Naveed Sattar
JACC. Advances|March 18, 2025
Elevated Lipoprotein(a) Is Common in People With Familial Hypercholesterolemia and Negative Genetic ScreeningFrancis Gainsborough, Paul Welsh, Naveed Sattar, et al.
British Journal of Haematology|March 29, 2008
Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA studyPaul Welsh, Mark Woodward, Ann Rumley, et al.
The New England Journal of Medicine|April 8, 2011
Vitamin D insufficiencyPaul Welsh, Mike J L Peters, Naveed Sattar
Current Opinion in Lipidology|June 8, 2018
Metformin, lipids and atherosclerosis preventionAlicia J Jenkins, Paul Welsh, John R Petrie
Cytokine|July 8, 2009
Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction StudyPaul Welsh, Mark Woodward, Ann Rumley, et al.
Circulation|December 10, 2019
Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease"Paul Welsh, Claire Welsh, Jill Pell, et al.
Arthritis and Rheumatism|March 15, 2011
Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementationPaul Welsh, Mike J L Peters, Naveed Sattar
Pageof 33

Showing results (11-20 of 328) with videos related to

Sort By:
Pageof 33
Open Heart|January 14, 2021
Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease eventsRosemary Elisabeth Brown, Paul Welsh, Jennifer Logue
Heart (British Cardiac Society)|January 17, 2025
Updating the Scottish national cardiovascular risk score: ASSIGN version 2.0Paul Welsh, Dorien M Kimenai, Mark Woodward
Current Opinion in Lipidology|October 30, 2008
Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the barPaul Welsh, Chris J Packard, Naveed Sattar
JACC. Advances|March 18, 2025
Elevated Lipoprotein(a) Is Common in People With Familial Hypercholesterolemia and Negative Genetic ScreeningFrancis Gainsborough, Paul Welsh, Naveed Sattar, et al.
British Journal of Haematology|March 29, 2008
Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA studyPaul Welsh, Mark Woodward, Ann Rumley, et al.
The New England Journal of Medicine|April 8, 2011
Vitamin D insufficiencyPaul Welsh, Mike J L Peters, Naveed Sattar
Current Opinion in Lipidology|June 8, 2018
Metformin, lipids and atherosclerosis preventionAlicia J Jenkins, Paul Welsh, John R Petrie
Cytokine|July 8, 2009
Associations of circulating TNFalpha and IL-18 with myocardial infarction and cardiovascular risk markers: the Glasgow Myocardial Infarction StudyPaul Welsh, Mark Woodward, Ann Rumley, et al.
Circulation|December 10, 2019
Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease"Paul Welsh, Claire Welsh, Jill Pell, et al.
Arthritis and Rheumatism|March 15, 2011
Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? The need to improve the evidence base prior to calls for supplementationPaul Welsh, Mike J L Peters, Naveed Sattar
Pageof 33